ALB and metabolic dysfunction-associated steatotic liver disease: Furthermore, T2DM patients with NAFLD had a higher BMI, WHR, WHtR, diastolic pressure, SUA, TG, ALT, AST, GGT, TP, albumin, fasting C-Peptide, and fasting insulin levels, but a lower low-density lipoprotein cholesterol (LDL-c) than those without NAFLD.